Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 150

2.

Effect of interleukin-1 beta converting enzyme inhibitor on acute myelogenous leukemia progenitor proliferation.

Estrov Z, Black RA, Sleath PR, Harris D, Van Q, LaPushin R, Estey EH, Talpaz M.

Blood. 1995 Dec 15;86(12):4594-602.

4.

Modulation of cell proliferation and cytokine production in acute myeloblastic leukemia by interleukin-1 receptor antagonist and lack of its expression by leukemic cells.

Rambaldi A, Torcia M, Bettoni S, Vannier E, Barbui T, Shaw AR, Dinarello CA, Cozzolino F.

Blood. 1991 Dec 15;78(12):3248-53.

5.
6.

Role of interleukin-1 beta converting enzyme (ICE) in leukemia.

Estrov Z, Talpaz M.

Cytokines Mol Ther. 1996 Mar;2(1):1-11. Review.

PMID:
9384684
7.
8.
9.

Evidence for internal autocrine regulation of growth in acute myeloblastic leukemia cells.

Rogers SY, Bradbury D, Kozlowski R, Russell NH.

Exp Hematol. 1994 Jul;22(7):593-8.

PMID:
7516889
10.
11.
12.

Modulation of cell proliferation and cytokine production in AML by recombinant interleukin-1 receptor antagonist.

Rambaldi A, Torcia M, Dinarello CA, Barbui T, Cozzolino F.

Leukemia. 1993 Aug;7 Suppl 2:S10-2.

PMID:
8361209
13.

Role of suramin as an IL-1 inhibitor in suppression of acute myelogenous leukemia progenitor proliferation.

Estrov Z, Talpaz M, Estey EH, Strassmann G.

Exp Hematol. 1995 Sep;23(10):1080-7.

PMID:
7544738
14.

Thrombopoietin and interleukin 11 have different modulatory effects on cell cycle and programmed cell death in primary acute myeloid leukemia cells.

Tafuri A, Lemoli RM, Petrucci MT, Ricciardi MR, Fogli M, Bonsi L, Ariola C, Strippoli P, Gregorj C, Petti MC, Tura S, Mandelli F, Bagnara GP.

Exp Hematol. 1999 Aug;27(8):1255-63.

PMID:
10428502
15.

The intracellular IL-1 receptor antagonist alters IL-1-inducible gene expression without blocking exogenous signaling by IL-1 beta.

Watson JM, Lofquist AK, Rinehart CA, Olsen JC, Makarov SS, Kaufman DG, Haskill JS.

J Immunol. 1995 Nov 1;155(9):4467-75.

PMID:
7594609
16.

Relations between IL-3-induced proliferation and in vitro cytokine secretion of bone marrow cells from AML patients.

Nowak R, Oelschlägel U, Gurth H, Range U, Albrecht S, Krebs U, Hietschold V, Ehninger G.

Cytokine. 1999 Jun;11(6):435-42.

PMID:
10346983
17.

Comparison of megakaryopoiesis in vitro of paired peripheral blood progenitor cells and bone marrow harvested during remission in patients with acute myeloid leukaemia.

Briggs M, Adams JA, Brereton ML, Burgess R, Hyde K, Lenehan H, Yin JA.

Br J Haematol. 2001 Dec;115(3):563-8.

PMID:
11736936
19.

Impact of in vivo administration of interleukin 3 on proliferation, differentiation, and chemosensitivity of acute myeloid leukemia.

Gore SD, Weng LJ, Jones RJ, Cowan K, Zilcha M, Piantadosi S, Burke PJ.

Clin Cancer Res. 1995 Mar;1(3):295-303.

Supplemental Content

Support Center